Incidence of cutaneous T cell lymphoma and other rare skin cancers in a defined population - 06/10/17

Doi : 10.1016/0190-9622(90)70208-Y

Tsu-Yi Chuang, MD, MPH ^{^{*
Visiting Scientist at the Section of Clinical Epidemiology. Permanent address: Section of Dermatology, Department of Medicine, University of Wisconsin and Dermatology Section, Medical Services, Wm. S. Middleton Memorial Veterans Administration Hospital, Madison, Wis.},}^⁎,^{^{1
From the Department of Dermatology, Mayo Clinic and Mayo Foundation.}}, W.P. Daniel Su, MD ^{^{1
From the Department of Dermatology, Mayo Clinic and Mayo Foundation.}}, Sigfrid A. Muller, MD ^{^{1
From the Department of Dermatology, Mayo Clinic and Mayo Foundation.}}
Rochester, Minnesota, USA

^‡Reprint requests: Tsu-Yi Chuang, MD, Section of Dermatology, University of Wisconsin Hospital & Clinics, 600 Highland Ave., J5/214 CSC, Madison, WI 53792.

Résumé

Between 1970 and 1984 in Rochester, Minnesota, rare skin cancers developed in 15 local residents: cutaneous T cell lymphoma (six subjects), dermatofibrosarcoma protuberans (four), adenocarcinoma of sweat glands (two), Merkel cell carcinoma (one), liposarcoma (one), and extramammary Paget's disease (one). These cases were identified through a unique computerized retrieval system that is maintained at the Mayo Clinic for the population of Rochester, Minnesota. The annual incidences of these cancers in the Rochester population were 0.9, 0.5,0.3,0.2,0.2, and 0.2 per 100,000 residents, respectively (standardized to 1980 U.S. population). To our knowledge, this is the first report of the incidences of these rare skin cancers in a well-defined population.

Le texte complet de cet article est disponible en PDF.

†

Supported in part by Veterans Administration Merit Review Board Grant (V-609P-1265), General Research Support Grant from the National Institutes of Health to the University of Wisconsin Medical School, the University of Wisconsin R&D Grant, and Research Grant AR-30582 from the National Institutes of Health awarded to the Mayo Clinic.